Filter
3445
Filtered Results: 3445
Text search:
drug
safety
Featured
Recommendations
365
New Publications
961
Language
Document type
No document type
2009
Guidelines
550
Studies & Reports
450
Manuals
174
Strategic & Response Plan
119
Fact sheets
56
Training Material
43
Situation Updates
15
Infographics
10
Resource Platforms
8
Brochures
6
Online Courses
4
App
1
Countries / Regions
India
186
Kenya
105
Global
87
South Africa
86
Ethiopia
83
Uganda
75
Nigeria
71
Western and Central Europe
66
Sierra Leone
61
Liberia
57
Tanzania
54
Nepal
53
Myanmar / Burma
51
Zambia
50
Malawi
48
Bangladesh
45
Latin America and the Carribbean
44
Ghana
43
Africa
43
Philippines
36
Namibia
35
Rwanda
32
Zimbabwe
27
Eastern Europe
25
Russia
23
Syria
22
Cambodia
22
Ukraine
21
Lesotho
20
Asia
20
South–East Asia Region
18
Germany
17
Indonesia
17
Botswana
17
Brazil
15
Congo, Democratic Republic of
14
Middle East and North Africa
14
USA
13
Eastern Europe and Central Asia
13
South Sudan
12
East and Southern Africa
12
West and Central Africa
12
Eswatini/ Swaziland
11
Chile
10
Burkina Faso
9
Haiti
9
Mozambique
9
Senegal
8
Cameroon
8
Pakistan
8
Guinea
7
Albania
7
Tajikistan
7
Vietnam
7
Afghanistan
6
Thailand
6
Yemen
6
Venezuela
6
Colombia
5
Western Pacific Region
5
Laos
5
Iraq
4
Sudan
4
Argentina
4
Angola
4
Georgia
4
Guinea-Bissau
3
Somalia
3
Turkey
3
China
3
Peru
3
Libya
3
Paraguay
3
Bhutan
3
Moldova
3
United Kingdom
3
Spain
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Jordan
2
Lebanon
2
Central African Republic
2
North Macedonia
2
Switzerland
2
El Salvador
2
Sri Lanka
2
Palestine
2
Southern Africa
2
Canada
2
Timor Leste/ East Timor
2
Uzbekistan
2
Saudi Arabia
1
Gambia
1
Ireland
1
Singapore
1
Papua New Guinea
1
Benin
1
Austria
1
Serbia
1
Honduras
1
Bolivia
1
Madagascar
1
Mexico
1
Fiji
1
Poland
1
Armenia
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Australia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
1305
Clinical Guidelines
350
Public Health
181
Women & Child Health
155
Key Resources
96
Capacity Building
52
Pharmacy & Technologies
48
Toolboxes
HIV
329
Mental Health
321
TB
249
AMR
223
COVID-19
215
Pharmacy
162
Caregiver
83
NTDs
81
Rapid Response
78
Ebola
72
Planetary Health
59
NCDs
59
Refugee
50
Conflict
45
Global Health Education
39
Disability
29
Specific Hazards
20
Natural Hazards
19
Cholera
17
Zika
16
Polio
13
Health Financing Toolbox
11
Social Ethics
6
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives and whether the world’s deadliest pandemic is overcome.
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
National action plans on antimicrobial resistance (AMR) often overlook the critical intersection of gender, despite evidence that exposure and susceptibility to infection, health-seeking behaviours, as well as antimicrobial prescribing and use patterns are all influenced by gender.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr...
Uganda is Africa's largest refugee-hosting country and ranks fifth globally. Over the decades, Uganda has hosted refugees from nations including South Sudan, the Democratic Republic of Congo, Eritrea, Somalia, Sudan, Burundi, and Rwanda. As of early 2024, it hosts 1 600 000 refugees, primarily in re...
Asthma prevalence is increasing worldwide and surveys indicate that the majority of patients in developed and developing countries do not receive optimal care and are therefore not well controlled. The aim of these guidelines is to promote a better standard of treatment based on advances in the unde...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
As our world changes, so too does the burden of disease. Globalisation, evolving trade and consumption patterns, and increased access to life-saving medical care are just some of the factors that have transformed the global health landscape.
This document provides a list of key WHO-recommended maternal and newborn health commodities and aims to accelerate progress towards the SDGs. It consolidates the key and enabling commodities from existing WHO guidelines on maternal and newborn health.
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and parasites no longer respond to these medicines, ren...
Globally, 85,000 women and girls were killed intentionally in 2023. 60 per cent of these homicides—51,000—were committed by an intimate partner or other family member. 140 women and girls die every day at the hands of their partner or a close relative, which means one woman or girl is killed eve...
The social protection landscape for people affected by TB in the WHO South-East Asia Region
Pneumonia and diarrhoea account for 23% of under-five mortality and were responsible for an estimated 1.17 million deaths in children under five globally. Furthermore, pneumonia and diarrhoea were responsible for 18% of mortality in children 5–9 years of age, resulting in an estimated 86 000 preve...
